PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding. Pfizer Inc's share price for the quarter that ended in Mar. 2014 was $32.12. Pfizer Inc's shares outstanding for the quarter that ended in Mar. 2014 was 6,383 Mil. Therefore, Pfizer Inc's market cap for the quarter that ended in Mar. 2014 was $194,041 Mil.
Pfizer Inc's quarterly market cap increased from Sep. 2013 ($190,168 Mil) to Dec. 2013 ($198,515 Mil) and increased from Dec. 2013 ($198,515 Mil) to Mar. 2014 ($205,020 Mil).
Pfizer Inc's annual market cap increased from Dec. 2011 ($163,923 Mil) to Dec. 2012 ($182,475 Mil) and increased from Dec. 2012 ($182,475 Mil) to Dec. 2013 ($198,515 Mil).
Enterprise value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pfizer Inc's enterprise value for Today is $197,459 Mil.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pfizer Inc's Market Cap for the fiscal year that ended in Dec. 2013 is calculated as
|Market Cap (A: Dec. 2013 )||=||Share Price (A: Dec. 2013 )||*||Shares Outstanding (A: Dec. 2013 )|
Pfizer Inc's Market Cap for the quarter that ended in Mar. 2014 is calculated as
|Market Cap (Q: Mar. 2014 )||=||Share Price (Q: Mar. 2014 )||*||Shares Outstanding (Q: Mar. 2014 )|
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pfizer Inc Annual Data
Pfizer Inc Quarterly Data